Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis
Clinical trial NCT02896127 · COMPLETED
Trial details
- NCT number
- NCT02896127
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-18
- Primary completion
- 2018-05-14
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.